FORX-06-428

N/A

Report date: 2026/04/30 10:43:58

Base Information

Drug NameFORX-06-428
Drug Alias NameFORX-06-428FoRx-428
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly(ADP-ribose) glycohydrolase inhibitors
TargetsPoly(ADP-ribose) glycohydrolase
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFoRx Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesFoRx Therapeutics AG
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A